188 related articles for article (PubMed ID: 38531599)
1. ESKtides: a comprehensive database and mining method for ESKAPE phage-derived antimicrobial peptides.
Wu H; Chen R; Li X; Zhang Y; Zhang J; Yang Y; Wan J; Zhou Y; Chen H; Li J; Li R; Zou G
Database (Oxford); 2024 Mar; 2024():. PubMed ID: 38531599
[TBL] [Abstract][Full Text] [Related]
2. PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.
Euler CW; Raz A; Hernandez A; Serrano A; Xu S; Andersson M; Zou G; Zhang Y; Fischetti VA; Li J
Antimicrob Agents Chemother; 2023 May; 67(5):e0151922. PubMed ID: 37098944
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
4. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
Chang RYK; Nang SC; Chan HK; Li J
Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant
Samir S; El-Far A; Okasha H; Mahdy R; Samir F; Nasr S
Saudi J Biol Sci; 2022 May; 29(5):3097-3106. PubMed ID: 35360502
[TBL] [Abstract][Full Text] [Related]
6. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
PeerJ; 2023; 11():e15007. PubMed ID: 37013147
[TBL] [Abstract][Full Text] [Related]
7. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
[TBL] [Abstract][Full Text] [Related]
8. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria.
Latz S; Wahida A; Arif A; Häfner H; Hoß M; Ritter K; Horz HP
J Basic Microbiol; 2016 Oct; 56(10):1117-1123. PubMed ID: 27194637
[TBL] [Abstract][Full Text] [Related]
9. [System analysis of the ecological distribution of bacteriophages in hospital wastewater].
Lu JY; Pan HW; Sun EH; Li W; Wang HX; Zhao XL; Wang HC
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):241-247. PubMed ID: 38387957
[TBL] [Abstract][Full Text] [Related]
10. Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.
Cavallazzi Sebold B; Li J; Ni G; Fu Q; Li H; Liu X; Wang T
BioDrugs; 2023 Sep; 37(5):607-623. PubMed ID: 37300748
[TBL] [Abstract][Full Text] [Related]
11. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
Pandey R; Mishra SK; Shrestha A
Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
[TBL] [Abstract][Full Text] [Related]
14. Alternatives for the treatment of infections caused by ESKAPE pathogens.
da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
[TBL] [Abstract][Full Text] [Related]
15. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
16. Genomic Epidemiological Analysis of Antimicrobial-Resistant Bacteria with Nanopore Sequencing.
Suzuki M; Hashimoto Y; Hirabayashi A; Yahara K; Yoshida M; Fukano H; Hoshino Y; Shibayama K; Tomita H
Methods Mol Biol; 2023; 2632():227-246. PubMed ID: 36781732
[TBL] [Abstract][Full Text] [Related]
17. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.
Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C
Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens.
Kondo K; Kawano M; Sugai M
mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial potential of the Mayan medicine plant Matayba oppositifolia (A. Rich.) Britton against antibiotic-resistant priority pathogens.
de Jesús Dzul-Beh A; Uc-Cachón AH; González-Sánchez AA; Dzib-Baak HE; Ortiz-Andrade R; Barrios-García HB; Jiménez-Delgadillo B; Molina-Salinas GM
J Ethnopharmacol; 2023 Jan; 300():115738. PubMed ID: 36165961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]